NO2006013I2 - Humant parathyreoidahormon (Humant parathyroid hormon) - Google Patents
Humant parathyreoidahormon (Humant parathyroid hormon)Info
- Publication number
- NO2006013I2 NO2006013I2 NO2006013C NO2006013C NO2006013I2 NO 2006013 I2 NO2006013 I2 NO 2006013I2 NO 2006013 C NO2006013 C NO 2006013C NO 2006013 C NO2006013 C NO 2006013C NO 2006013 I2 NO2006013 I2 NO 2006013I2
- Authority
- NO
- Norway
- Prior art keywords
- parathyroid hormone
- human parathyroid
- human
- ultrapure
- hormone
- Prior art date
Links
- 101001135770 Homo sapiens Parathyroid hormone Proteins 0.000 title abstract 4
- 101001135995 Homo sapiens Probable peptidyl-tRNA hydrolase Proteins 0.000 title abstract 4
- 102000058004 human PTH Human genes 0.000 title abstract 4
- 238000004458 analytical method Methods 0.000 abstract 1
- 238000005251 capillar electrophoresis Methods 0.000 abstract 1
- 239000000356 contaminant Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Steroid Compounds (AREA)
- Pyrane Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Glass Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/707,114 US5208041A (en) | 1991-05-23 | 1991-05-23 | Essentially pure human parathyroid hormone |
Publications (2)
Publication Number | Publication Date |
---|---|
NO2006013I1 NO2006013I1 (no) | 2006-11-06 |
NO2006013I2 true NO2006013I2 (no) | 2009-12-07 |
Family
ID=24840399
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19922000A NO304190B1 (no) | 1991-05-23 | 1992-05-21 | Rent parathyroid hormon, fremgangsmÕte for dets fremstilling samt farmasoytisk sammensetning inneholdende det |
NO2006013C NO2006013I2 (no) | 1991-05-23 | 2006-10-24 | Humant parathyreoidahormon (Humant parathyroid hormon) |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19922000A NO304190B1 (no) | 1991-05-23 | 1992-05-21 | Rent parathyroid hormon, fremgangsmÕte for dets fremstilling samt farmasoytisk sammensetning inneholdende det |
Country Status (16)
Country | Link |
---|---|
US (1) | US5208041A (no) |
EP (1) | EP0515228B1 (no) |
JP (1) | JP2563726B2 (no) |
KR (1) | KR970007755B1 (no) |
AT (1) | ATE164394T1 (no) |
CA (1) | CA2068438C (no) |
DE (1) | DE69224858T2 (no) |
DK (1) | DK0515228T3 (no) |
ES (1) | ES2115642T3 (no) |
FI (1) | FI106802B (no) |
HK (1) | HK1004340A1 (no) |
IE (1) | IE921672A1 (no) |
IL (3) | IL119840A (no) |
NO (2) | NO304190B1 (no) |
NZ (1) | NZ242855A (no) |
ZA (1) | ZA923735B (no) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5420242A (en) * | 1986-10-22 | 1995-05-30 | Kaare M. Gautvik | Production of human parathyroid hormone from microorganisms |
USRE37919E1 (en) | 1989-05-12 | 2002-12-03 | The General Hospital Corporation | Recombinant DNA method for production of parathyroid hormone |
WO1995011697A1 (fr) * | 1993-10-27 | 1995-05-04 | Chugai Seiyaku Kabushiki Kaisha | Accelerateur de guerison utilise en chondroplastie |
US20020193338A1 (en) * | 1994-02-18 | 2002-12-19 | Goldstein Steven A. | In vivo gene transfer methods for wound healing |
US5942496A (en) | 1994-02-18 | 1999-08-24 | The Regent Of The University Of Michigan | Methods and compositions for multiple gene transfer into bone cells |
US5962427A (en) | 1994-02-18 | 1999-10-05 | The Regent Of The University Of Michigan | In vivo gene transfer methods for wound healing |
US6074840A (en) | 1994-02-18 | 2000-06-13 | The Regents Of The University Of Michigan | Recombinant production of latent TGF-beta binding protein-3 (LTBP-3) |
US5763416A (en) | 1994-02-18 | 1998-06-09 | The Regent Of The University Of Michigan | Gene transfer into bone cells and tissues |
US6551618B2 (en) | 1994-03-15 | 2003-04-22 | University Of Birmingham | Compositions and methods for delivery of agents for neuronal regeneration and survival |
US7923250B2 (en) | 1997-07-30 | 2011-04-12 | Warsaw Orthopedic, Inc. | Methods of expressing LIM mineralization protein in non-osseous cells |
DE69840361D1 (de) | 1997-07-30 | 2009-01-29 | Univ Emory | Neue knochenmineralisierungsproteine, dna, vektoren, expressionssysteme |
US6770623B1 (en) | 1997-12-09 | 2004-08-03 | Eli Lilly And Company | Stabilized teriparatide solutions |
AR033639A1 (es) | 1998-08-19 | 2004-01-07 | Lilly Co Eli | Uso de hormonas paratiroideas para preparar medicamentos para reducir el riesgo de fracturas oseas vertebrales o no vertebrales en seres humanos con riesgo de padecer o que padecen osteoporosis |
EP1123401A1 (en) * | 1998-10-22 | 2001-08-16 | The General Hospital Corporation | BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP) |
AU4217299A (en) | 1998-11-30 | 2000-06-19 | General Hospital Corporation, The | Pth1r and pth3r receptors, methods and uses thereof |
US7820393B2 (en) * | 1999-01-14 | 2010-10-26 | Scantibodies Laboratory, Inc. | Methods, kits and antibodies for detecting parathyroid hormone |
US6689566B1 (en) | 1999-01-14 | 2004-02-10 | Scantibodies Laboratory, Inc. | Methods, kits, and antibodies for detecting parathyroid hormone |
US20080108086A1 (en) * | 1999-06-02 | 2008-05-08 | Cantor Thomas L | Parathyroid hormone antagonists and uses thereof |
WO2004028444A2 (en) * | 1999-06-02 | 2004-04-08 | Scantibodies Laboratory, Inc. | Parathyroid hormone antagonists and uses thereof |
AU7734800A (en) * | 1999-09-29 | 2001-04-30 | General Hospital Corporation, The | Polypeptide derivatives of parathyroid hormone (pth) |
CN100518819C (zh) * | 2000-06-30 | 2009-07-29 | 阿斯比奥制药株式会社 | 含有人甲状旁腺激素的药物成分及含有该成分的用于鼻内给药的药物组合物 |
US6905886B2 (en) * | 2000-08-11 | 2005-06-14 | Quest Diagnostics Investments Incorporated | Preservative solutions |
US6387711B1 (en) * | 2000-08-11 | 2002-05-14 | Quest Diagnostics Investments Incorporated | Liquid intact parathyroid hormone (PTH) standards |
CA2454275C (en) * | 2001-07-23 | 2012-10-23 | The General Hospital Corporation | Conformationally constrained parathyroid hormone (pth) analogs |
US20040067526A1 (en) * | 2002-10-03 | 2004-04-08 | Cantor Thomas L. | Methods for diagnosing and guiding treatment of bone turnover disease |
EP1610813A4 (en) * | 2003-03-19 | 2009-07-01 | Gen Hospital Corp | PARATHYROIDAL HORMONES CONFORMALLY CONFORMALLY CONSTRAINED WITH PROPELLER STABILIZERS $ G (A) |
KR100540659B1 (ko) * | 2003-07-02 | 2006-01-10 | 삼성전자주식회사 | 이미지 확대 인쇄 방법과 장치 및 컴퓨터 프로그램을저장하는 컴퓨터로 읽을 수 있는 기록 매체 |
US7910544B2 (en) | 2003-07-17 | 2011-03-22 | The General Hospital Corporation | Conformationally constrained parthyroid hormone (PTH) analogs |
CA2566032A1 (en) * | 2004-05-13 | 2005-12-01 | Alza Corporation | Apparatus and method for transdermal delivery of parathyroid hormone agents |
US7541140B2 (en) * | 2004-06-03 | 2009-06-02 | Scantibodies Laboratory, Inc. | Assessing risk for kidney stones using parathyroid hormone agonist and antagonist |
WO2007059470A2 (en) * | 2005-11-10 | 2007-05-24 | Board Of Control Of Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
EP2054077A4 (en) * | 2006-08-04 | 2010-10-13 | Gen Hospital Corp | POLYPEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) |
EP2187902B1 (en) * | 2007-08-01 | 2013-04-17 | The General Hospital Corporation | Screening methods using g-protein coupled receptors and related compositions |
RU2441019C2 (ru) * | 2007-08-09 | 2012-01-27 | Юсв Лимитед | Способ синтеза рекомбинантного паратиреоидного гормона человека |
PT2464655T (pt) * | 2009-08-11 | 2017-05-25 | Biocon Ltd | Processos cromatográficos |
AU2009356227A1 (en) | 2009-12-07 | 2012-06-21 | Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
RU2604809C2 (ru) | 2010-05-13 | 2016-12-10 | Дзе Дженерал Хоспитал Корпорейшн | Аналоги паратиреоидного гормона и их применение |
US20140088014A1 (en) | 2011-06-07 | 2014-03-27 | Asahi Kasei Pharma Corporation | Freeze-dried preparation containing high-purity pth and method for producing same |
CN102993293B (zh) * | 2012-12-05 | 2014-05-07 | 深圳翰宇药业股份有限公司 | 一种特立帕肽醋酸盐的纯化方法 |
LU100168B1 (en) | 2017-04-12 | 2018-10-15 | Michael Pazianas | Prevention of Bone and Mineral Disorders by Restoring Calcium and Phosphate Homeostasis in Patients Suffering from Chronic Kidney Disease |
US20230190880A1 (en) | 2020-03-30 | 2023-06-22 | Sichuan Luzhou Buchang Bio-Pharmaceutical Co., Ltd. | Formulations of Human Parathyroid Hormone (PTH) and Methods for Producing Same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3886132A (en) * | 1972-12-21 | 1975-05-27 | Us Health | Human parathyroid hormone |
US5223407A (en) * | 1988-08-31 | 1993-06-29 | Allelix Inc. | Excretion of heterologous proteins from e. coli |
AU6448990A (en) * | 1989-09-29 | 1991-04-28 | Her Majesty in Right of Canada, as represented by National Research Council Canada | Synthesis of mature human parathyroid hormone |
-
1991
- 1991-05-23 US US07/707,114 patent/US5208041A/en not_active Expired - Lifetime
-
1992
- 1992-05-11 IL IL11984092A patent/IL119840A/xx not_active IP Right Cessation
- 1992-05-11 IL IL10182992A patent/IL101829A/en not_active IP Right Cessation
- 1992-05-12 CA CA002068438A patent/CA2068438C/en not_active Expired - Lifetime
- 1992-05-21 NO NO19922000A patent/NO304190B1/no not_active IP Right Cessation
- 1992-05-21 NZ NZ242855A patent/NZ242855A/xx not_active IP Right Cessation
- 1992-05-22 KR KR92008730A patent/KR970007755B1/ko not_active IP Right Cessation
- 1992-05-22 AT AT92304692T patent/ATE164394T1/de active
- 1992-05-22 DK DK92304692T patent/DK0515228T3/da active
- 1992-05-22 EP EP92304692A patent/EP0515228B1/en not_active Expired - Lifetime
- 1992-05-22 DE DE69224858T patent/DE69224858T2/de not_active Expired - Lifetime
- 1992-05-22 ZA ZA923735A patent/ZA923735B/xx unknown
- 1992-05-22 ES ES92304692T patent/ES2115642T3/es not_active Expired - Lifetime
- 1992-05-22 FI FI922356A patent/FI106802B/fi not_active IP Right Cessation
- 1992-05-22 JP JP4156100A patent/JP2563726B2/ja not_active Expired - Lifetime
- 1992-07-01 IE IE167292A patent/IE921672A1/en not_active IP Right Cessation
-
1996
- 1996-12-16 IL IL11984096A patent/IL119840A0/xx unknown
-
1998
- 1998-04-24 HK HK98103454A patent/HK1004340A1/xx not_active IP Right Cessation
-
2006
- 2006-10-24 NO NO2006013C patent/NO2006013I2/no unknown
Also Published As
Publication number | Publication date |
---|---|
IE921672A1 (en) | 1992-12-02 |
NO2006013I1 (no) | 2006-11-06 |
IL101829A (en) | 1999-12-31 |
FI922356A0 (fi) | 1992-05-22 |
FI922356A (fi) | 1992-11-24 |
EP0515228A2 (en) | 1992-11-25 |
NO922000D0 (no) | 1992-05-21 |
NO304190B1 (no) | 1998-11-09 |
US5208041A (en) | 1993-05-04 |
AU639856B2 (en) | 1993-08-05 |
JP2563726B2 (ja) | 1996-12-18 |
ATE164394T1 (de) | 1998-04-15 |
DE69224858D1 (de) | 1998-04-30 |
HK1004340A1 (en) | 1998-11-20 |
ES2115642T3 (es) | 1998-07-01 |
DE69224858T2 (de) | 1998-07-23 |
EP0515228A3 (no) | 1994-05-04 |
DK0515228T3 (da) | 1998-09-28 |
KR970007755B1 (en) | 1997-05-16 |
NZ242855A (en) | 1994-04-27 |
FI106802B (fi) | 2001-04-12 |
NO922000L (no) | 1992-11-24 |
IL119840A0 (en) | 1997-03-18 |
CA2068438C (en) | 1996-11-12 |
ZA923735B (en) | 1993-01-27 |
IL119840A (en) | 2005-08-31 |
AU1604992A (en) | 1993-03-11 |
IL101829A0 (en) | 1992-12-30 |
EP0515228B1 (en) | 1998-03-25 |
JPH0687897A (ja) | 1994-03-29 |
CA2068438A1 (en) | 1992-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2006013I1 (no) | Humant parathyreoidahormon (humant parathyroid hormon) | |
DE3680997D1 (de) | Einrichtung zur als sprache empfundenen rueckkopplung. | |
KR850004664A (ko) | 자연어에 의한 지적가이던스방법(知的 guidence 方法) 및 그 장치 | |
FI97893B (fi) | Isoelektrinen fokusointimenetelmä ja laite mainitun menetelmän suorittamiseksi | |
DE219220T1 (de) | Verfahren und zusammensetzung zur gleichzeitigen reinigung und desinfektion von kontaktlinsen. | |
DE3682249D1 (de) | Verfahren zur bildbearbeitung und geraet zur bilderzeugung. | |
DE3177273D1 (de) | Rinder-prowachstums- und -wachstumshormon. | |
NO901026L (no) | Anordning og fremgangsmaate for naturlig spraakanalysering. | |
ATE78590T1 (de) | Probennehmer. | |
NO920703L (no) | Fusjonsproteiner som omfatter gm-csf og il-3 | |
DE3853301T2 (de) | Verfahren und Vorrichtung zur Positionierung von Vorlagen in Bildabtastern. | |
DE69127999D1 (de) | Interne-Standard zur elektrophoretischen Trennung | |
DE3685043D1 (de) | Linsenmessgeraet und messverfahren dazu fuer gleitsichtlinsen. | |
DE3851609D1 (de) | Gerät zur Inspektion von Walzzeichen. | |
DE3562815D1 (de) | Oparation device for valves | |
ATE148923T1 (de) | Funktioneller test und reagenz zur bestimmung von fibrinogen | |
GR851623B (no) | ||
DE3787723T2 (de) | Gerät zur kontaminationsanalyse. | |
DK639089D0 (da) | Fremgangsmaade til oploeseliggoerelse og naturering af somatotropin | |
DK232988D0 (da) | Fremgangsmaade til immunologisk bestemmelse af aminoterminalt prokollagen peptidtype iii og antistoffer til gennemfoerelse heraf. | |
FR2714768B1 (fr) | Dispositif de balayage électronique à lentille active et source illuminatrice intégrée. | |
IT8721387A0 (it) | Procedimento e dispositivo per infilare uno stoppino in uno stiratoio in funzione. | |
IT8404872A0 (it) | Procedimento e dispositivo di taratura per un ingranditore o riproduttore fotografico. | |
DE69122612T2 (de) | Interleukin-4-bindeprotein-gamma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: SHIRE-NPS PHARMACEUTICALS, US |